Market News
Latest news from Stock markets.
Blue Owl: Redemptions Panic Creates A Hard-To-Miss Opportunity (Rating Upgrade)
Blue Owl Capital faces peak redemption pressures, but I see this as a capitulation point and now upgrade the stock to buy. Direct lending fees drive over 60% of 2025 adjusted revenue, with private wealth redemptions concentrated among a small minority of investors. Despite redemption-driven volatility, OWL's liquidity remains robust, and outflows are modest relative to NAV, supporting business model resilience.
...keep reeding on seekingalpha.com
Rosen Law Firm Encourages Chanson International Holding Investors to Inquire About Securities Class Action Investigation - CHSN
NEW YORK, April 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Chanson International Holding (NASDAQ: CHSN) resulting from allegations that Chanson International Holding may have issued materially misleading business information to the investing public. So what: If you purchased Chanson International securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
Kuaishou Technology: Downgrade To Hold As Near-Term Setup Is Poor
Kuaishou Technology is downgraded to Hold as the near-term earnings outlook deteriorates amid surging AI capex and slower growth guidance. Management's 2026 guidance signals revenue growth of 4–4.5%, declining margins, and a 15–18% drop in adjusted earnings as capex jumps to RMB26B. Kling remains a bright spot, with ARR reaching $300M and FY2026 revenue expected to more than double, easing competitive concerns.
...keep reeding on seekingalpha.com
CMB.TECH: Valuation Implies Mid-Cycle - Reality Looks Stronger
CMB.TECH is now a highly leveraged play on freight rates, with over 80% spot exposure post-merger and tripled operating scale. Reported EPS is distorted by one-off Golden Ocean deal costs; normalized earnings and EBITDA provide a clearer view of CMBT's true earnings power. CMBT's valuation and investment case hinge on freight rate sensitivity, with current market cap implying mid-to-high cycle TCE rates ($35k–45k/day).
...keep reeding on seekingalpha.com
What Is the Jevons Paradox and What Does It Mean for Micron and Sandisk Investors After Google's Revolutionary AI Breakthrough?
Google's memory-compression algorithm caused Micron and Sandisk stocks to plunge. However, an obscure economics concept suggests it will increase demand for these companies' memory chips.
...keep reeding on fool.com
The Future of Warfare Is Drones. This Defense Stock Is Perfectly Positioned to Benefit.
The Strait of Hormuz closure is showing the importance of underwater superiority. Kraken Robotics is a key battery supplier for underwater drones, which are attracting massive government investments.
...keep reeding on fool.com
Could Investing $10,000 in SPYM Make You a Millionaire?
The State Street SPDR Portfolio S&P 500 ETF delivered average annual returns of 15.5% for the past 10 years. The fund tracks the performance of the S&P 500 index and charges an expense ratio of only 0.02%.
...keep reeding on fool.com
IT Investors Have Opportunity to Lead Gartner, Inc. Securities Fraud Lawsuit
NEW YORK, April 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Gartner, Inc. (NYSE: IT) between February 4, 2025 and February 2, 2026, both dates inclusive (the "Class Period"), of the important May 18, 2026 lead plaintiff deadline. So What: If you purchased Gartner common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
Rosen Law Firm Encourages SYLA Technologies Co., Ltd. Investors to Inquire About Securities Class Action Investigation - SYT
NEW YORK, April 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SYLA Technologies Co., Ltd. (NASDAQ: SYT) resulting from allegations that SYLA Technologies Co., Ltd.
...keep reeding on prnewswire.com
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, April 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) between May 20, 2024 and January 9, 2026, inclusive (the "Class Period"), of the important May 22, 2026 lead plaintiff deadline. So what: If you purchased Atara securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
Micron Could Be The Next Intel
Micron is positioned as a core enabler of AI, paralleling Intel's 1990s dominance in hardware. MU's valuation remains well below bubble territory, with earnings growth and PE expansion potential reminiscent of mid-1990s Intel. Micron's vertical focus on memory differentiates it from Intel's failed horizontal strategy, reinforcing its defensible market position.
...keep reeding on seekingalpha.com
DOOR Deadline: DOOR Investors Have Opportunity to Lead Masonite International Corporation Securities Fraud Lawsuit
NEW YORK, April 4, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June 5, 2023 and February 8, 2024, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline. So What: If you sold Masonite common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
U.S. IPO Weekly Recap: SpaceX Confidentially Files, Energy Play Goes Public, And More Defense Tech Joins The IPO Pipeline
One IPO priced this past week, joined by one SPAC, and one major deal joined the pipeline. One direct listing is currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week. Street research is expected for three companies in the week ahead, and six lock-up periods will be expiring.
...keep reeding on seekingalpha.com
JEPI vs. JEPQ: Which Is the Better Buy in April?
High yield and defensive strategies have outperformed the broader market in the current pullback. Covered call strategies can deliver the yield, but it's really more about the underlying stock portfolio.
...keep reeding on fool.com
Meta paused its work with AI training startup Mercor after a data breach
Meta has paused its work with Mercor and is investigating after a data breach, a person familiar said. Mercor confirmed to Business Insider that it was recently affected by a security incident.
...keep reeding on businessinsider.com
DoubleVerify: Strong Retention, Attractive Valuation
DoubleVerify is a compelling buy after a ~20% share price decline in the past year. Though investors are fearing weakened ad budgets and potential AI incursion, the company is showcasing strong revenue retention rates. DoubleVerify addresses a $27 billion TAM, which has expansion potential as it adds new products to track and measure AI ad spending.
...keep reeding on seekingalpha.com
Phoenix Education Partners: A Top Tier Play In For-Profit Education
Phoenix Education Partners is rated a strong buy due to rapid growth, deep value, and a robust balance sheet. PXED's revenue rose from $835M in 2023 to $1.02B in 2025, with enrollment and retention driving growth. Despite a recent cybersecurity incident and strategic expenses, adjusted net income and EBITDA continue to improve.
...keep reeding on seekingalpha.com
KKR: Still A Growth Story Despite Credit Fears
KKR remains a strong buy despite recent underperformance and sector-wide private credit fears, with shares trading near 52-week lows. KKR's long-dated, gated AUM structure ensures durable, stable fee revenue, largely insulated from immediate private credit market stresses. The recent $23 billion North American private equity fundraise, exceeding targets, demonstrates robust institutional demand and supports forward revenue growth.
...keep reeding on seekingalpha.com
This Under-the-Radar Fintech Stock Has Been Quietly Gaining Market Share
Sezzle has high revenue growth and issued solid guidance for fiscal 2026. The BNPL industry is riding a multiyear growth opportunity, and Sezzle is positioned as one of the leaders.
...keep reeding on fool.com
PAYSAFE DEADLINE: ROSEN, A NATIONALLY RECOGNIZED INVESTOR RIGHTS LAW FIRM, Encourages Paysafe Limited Investors with Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action - PSFE
New York, New York--(Newsfile Corp. - April 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Paysafe Limited (NYSE: PSFE) between March 4, 2025 and November 12, 2025, inclusive, (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline. SO WHAT: If you purchased Paysafe securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
Dividends Don't Lie: This Is the Most Reliable High-Yield REIT
Federal Realty has increased its dividend annually for 58 consecutive years. The strip mall and mixed-use landlord is the only REIT to have achieved Dividend King status.
...keep reeding on fool.com
INVESTOR NOTICE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit
SAN DIEGO, April 3, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ImmunityBio, Inc. (NASDAQ: IBRX) publicly traded securities between January 19, 2026 and March 24, 2026, inclusive (the "Class Period"), have until May 26, 2026 to seek appointment as lead plaintiff of the ImmunityBio class action lawsuit. Captioned Douglas v.
...keep reeding on prnewswire.com
Foundation for a Drug-Free World Volunteers Reach Athletes and Communities Across Italy During 2026 Winter Olympics
/PRNewswire/ -- During the 2026 Winter Olympics and Paralympics in Milano and Cortina, more than 600 volunteers with the Foundation for a Drug-Free World
...keep reeding on prnewswire.com
INVESTOR DEADLINE: Eos Energy Enterprises, Inc. (EOSE) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO, April 3, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Eos Energy Enterprises, Inc. (NASDAQ: EOSE) securities between November 5, 2025 and February 26, 2026, inclusive (the "Class Period"), have until Tuesday, May 5, 2026 to seek appointment as lead plaintiff of the Eos Energy class action lawsuit. Captioned Yung v.
...keep reeding on prnewswire.com
QLV: Sensible Quality And Low Volatility Strategy, Yet Outperformance Is Unlikely, A Hold
The FlexShares US Quality Low Volatility Index Fund ETF has a passive strategy bringing together quality and low volatility factors. QLV's portfolio has high quality, a 0.65 weighted average 24-month beta, and a value tilt, which should help the ETF to keep the downside capture below 80%. However, QLV does not have GARP characteristics appealing enough, plus low beta is a detractor from upside capture, so its outperformance versus IVV in 2026 and beyond is unlikely.
...keep reeding on seekingalpha.com
MBS: Mortgages Are Attractive After The Sell-Off
The Angel Oak Mortgage-Backed Securities ETF is indeed a standout for its "pure-play" focus on residential mortgage credit and its prime ticker symbol. As of early April 2026, the fund is navigating a volatile environment where geopolitical tensions (specifically the Iran conflict) have pushed Treasury yields up by 20–30 bps. With an effective duration of 5.7 years, MBS is more sensitive to rate hikes than short-term Treasury funds (like IEI), but it captures the "excess spread" from mortgages.
...keep reeding on seekingalpha.com
ANI Pharmaceuticals: Worthy Of A Position
ANI Pharmaceuticals recently offered up solid FY26 guidance with 15% non-GAAP EPS growth and strong momentum from Cortrophin Gel. ANIP's increasing reliance on Cortrophin Gel, projected to reach 52% of FY26 revenue, is offset by patent protection and a complex formulation. The company's balance sheet remains solid, supporting ongoing investments in rare disease expansion and 10–15 annual generic launches.
...keep reeding on seekingalpha.com
OpenAI sees a new round of executive shake-ups
OpenAI's leadership is reshuffling. COO Brad Lightcap is taking a new role to expand OpenAI's enterprise software sales.
...keep reeding on businessinsider.com
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Super Micro Computer, Inc. (SMCI) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, April 3, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Super Micro class action lawsuit – captioned Bhuva v. Super Micro Computer, Inc., No.
...keep reeding on prnewswire.com
Massive News for Intel Stock Investors
Intel (INTC +4.85%) is in a much better financial position than a couple of years ago, and this move was evidence of that.
...keep reeding on fool.com
Is Cloudflare Stock an Undervalued AI Stock to Buy?
Cloudflare (NET +2.82%) stock has held up relatively well amid fears of a broader economic slowdown.
...keep reeding on fool.com
Monster Stock Analysis: Buy or Sell?
The energy drink category is forecast to grow by double digits in 2026.
...keep reeding on fool.com
Tired of the Stock Market Volatility? 1 Relatively Safe Undervalued Dividend Stock You Can Buy
The risks of a global recession are increasing with soaring oil prices.
...keep reeding on fool.com
Stock Markets Crashing: My 15 Top-Ranked Stocks to Buy Now in April (2026)
There is something for everyone in this excellent list of undervalued stocks.
...keep reeding on fool.com
ROSEN, A LONGSTANDING FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST
New York, New York--(Newsfile Corp. - April 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026, both dates inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline. SO WHAT: If you purchased Aquestive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
$MCW DISCLOSES NEW DETAILS ABOUT ITS PENDING TAKE PRIVATE: Mister Car Wash, Inc. Shareholders are notified that the company has revealed new details about the pending transaction which are relevant to BFA Law's ongoing investigation into LGP's $7.00 per share Take Private Transaction
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP notifies stockholders of Mister Car Wash, Inc. (NASDAQ: MCW) that new details have emerged related to BFA Law's ongoing investigation into the company's board of directors and its controlling stockholder, LGP, for potential breaches of their fiduciary duties to shareholders in connection with the pending take-private sale of Mister Car Wash that is slated to cash out every public stockholder for $7 per share. If you are a current shareholder of Mister Car Wash, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/mister-car-wash-investigation.
...keep reeding on globenewswire.com
2 Closed-End Funds Worth A 'Buy'
The broader equity market has been softer lately, leading to some opportunities to put some cash to work. Given the increased volatility, this has also put pressure on closed-end funds, and we have started to see some discounts start to widen. Today, we take a look at two closed-end funds that provide investors with attractive distribution rates at attractive discounted valuations.
...keep reeding on seekingalpha.com
IBRX INVESTOR ALERT: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio securities between January 19, 2026 and March 24, 2026. The lawsuit follows news that the FDA sent a warning letter to the company concerning claims made by its executive chairman and Chief Scientific and Medical Officer (Dr. Patrick Soon-Shiong) regarding ImmunityBio's lead biologic product (Anktiva), which the FDA said were misleading efficacy claims.
...keep reeding on prnewswire.com
CEF Market Weekly Review: EM Debt Gives Back Some Outperformance
We review the CEF market valuation and performance through the last week of March and highlight recent market action. March marked the worst month for CEFs in over three years, with broad sector underperformance and widening discounts, except for Utilities and MLPs. Emerging Market debt CEFs like EDD experienced significant volatility due to FX moves, energy shocks, and pro-cyclical risk factors, challenging income investors' conviction.
...keep reeding on seekingalpha.com
COTY INVESTOR ALERT: Coty Inc. (COTY) Sued After Surprise Profit Decline, CEO Exit, and Withdrawn 2026 Guidance -- Hagens Berman
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- Coty Inc. (NYSE: COTY) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Coty common stock between November 5, 2025 and February 4, 2026. The lawsuit follows Coty's February 5, 2026 Q2 2026 earnings report, depicting serious operational issues, and the abrupt departure of its CEO (Sue Y.
...keep reeding on prnewswire.com
Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules securities between May 1, 2025 and February 27, 2026. The lawsuit follows Hunterbrook Media's critical report, "The Myth of Hercules Capital," which in part claims that Hercules' sourcing process for deals merely copies those published on Google Ventures' website.
...keep reeding on prnewswire.com
GEMI INVESTOR ALERT: Gemini (GEMI) Post-IPO Meltdown Sparks Securities Class Action as Investors Seek Recovery - Hagens Berman
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Gemini Space Station, Inc. (NASDAQ: GEMI) and its top executives, including founders Cameron and Tyler Winklevoss. The litigation follows a series of disclosures that have caused the company's stock to trade more than 75% below its initial public offering (IPO) price.
...keep reeding on prnewswire.com
ODD INVESTOR ALERT: ODDITY Tech. (ODD) Sued After Shares Plunge 49% on AI Platform Disruption and Revenue Decline -- Hagens Berman
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against ODDITY Tech. Ltd. (NASDAQ: ODD), seeking to represent investors who purchased ODDITY securities between February 26, 2025 and February 24, 2026.
...keep reeding on prnewswire.com
TCOM INVESTOR ALERT: Trip.com (TCOM) Facing Class Action After AI Pricing Controversy and Anti-Monopoly Probe Sends Shares Tumbling -- Hagens Berman
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against China's largest online travel agency, Trip.com Group (NASDAQ: TCOM), seeking to represent investors who purchased Trip.com securities between April 30, 2024 and January 13, 2026. The lawsuit follows the 17% decline in the price of Trip.com American Depositary Shares on January 14, 2026.
...keep reeding on prnewswire.com
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eos Energy Enterprises, Inc. (NASDAQ: EOSE) between November 5, 2025 and February 26, 2026, both dates inclusive (the “Class Period”), of the important May 5, 2026 lead plaintiff deadline.
...keep reeding on globenewswire.com
Fortinet Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortinet Inc. - FTNT
NEW YORK and NEW ORLEANS, April 3, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
...keep reeding on prnewswire.com
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation – ELWT
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially misleading business information to the investing public.
...keep reeding on globenewswire.com
ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc. - IBRX
NEW ORLEANS, April 3, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against ImmunityBio, Inc. (NasdaqGS: IBRX) ("ImmunityBio" or the "Company"), if they purchased or otherwise acquired the Company's securities between January 19, 2026 and March 24, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.
...keep reeding on prnewswire.com
Super Micro Computer Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Super Micro Computer, Inc. - SMCI
NEW ORLEANS, April 3, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Super Micro Computer, Inc. ("Super Micro" or the "Company") (NasdaqGS: SMCI), if they purchased or otherwise acquired the Company's securities between April 30, 2024 and March 19, 2026, (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
...keep reeding on prnewswire.com
Gemini Space Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Gemini Space Station, Inc. - GEMI
NEW ORLEANS, April 3, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 18, 2026 to file lead plaintiff applications in a securities class action lawsuit against Gemini Space Station, Inc. ("Gemini" or the "Company") (NasdaqGS: GEMI), if they purchased or otherwise acquired Gemini Class A common stock pursuant and/or traceable to the Company's September 12, 2025 initial public offering ("IPO"), and/or Gemini securities between September 12, 2025 and February 17, 2026 (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.
...keep reeding on prnewswire.com
Driven Brands Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Driven Brands Holdings Inc. - DRVN
NEW ORLEANS, April 3, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 8, 2026 to file lead plaintiff applications in a securities class action lawsuit against Driven Brands Holdings Inc. (NasdaqGS: DRVN) ("Driven" or the "Company"), if they purchased or otherwise acquired the Company's shares between May 9, 2023 and February 24, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.
...keep reeding on prnewswire.com